We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+6.72%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$616B
AUM Growth
+$31B
Cap. Flow
-$1.19B
Cap. Flow %
-0.19%
Top 10 Hldgs %
18.88%
Holding
2,692
New
121
Increased
947
Reduced
1,282
Closed
130

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.86B
2
VMW
VMware, Inc
VMW
+$1.49B
3
AVGO icon
Broadcom
AVGO
+$1.29B
4
SRE icon
Sempra
SRE
+$1.26B
5
BKNG icon
Booking.com
BKNG
+$1.12B

Sector Composition

Rank Sector Weight
1 Healthcare 17.07%
2 Financials 16.19%
3 Technology 16.15%
4 Consumer Discretionary 13.93%
5 Industrials 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMI icon
751
Cummins
CMI
$87B
$69.6M 0.01%
394,030
-95,858
-20% -$16.4M
APEI icon
752
American Public Education
APEI
$828M
$69.6M 0.01%
2,778,407
+30,880
+1% +$720K
TDOC icon
753
Teladoc Health
TDOC
$1.26B
$69.2M 0.01%
1,986,662
+135,695
+7% +$4.51M
HUBB icon
754
Hubbell
HUBB
$26.8B
$68.5M 0.01%
506,376
+324,135
+178% +$40.4M
CISN
755
DELISTED
Cision Ltd. Ordinary Share
CISN
$68M 0.01%
5,731,350
-43,500
-0.8% -$537K
ALL icon
756
Allstate
ALL
$65.9B
$68M 0.01%
649,014
-18,261
-3% -$1.8M
UBNK
757
DELISTED
United Financial Bancorp, Inc.
UBNK
$67.9M 0.01%
3,851,781
-138,000
-3% -$2.51M
WM icon
758
Waste Management
WM
$89.6B
$67.4M 0.01%
781,090
-25,154
-3% -$2.05M
ETFC
759
DELISTED
E*Trade Financial Corporation
ETFC
$67.2M 0.01%
1,355,342
-312,814
-19% -$14.4M
CCI.PRA
760
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
$66.9M 0.01%
60,202
-118,280
-66% -$131M
ECPG icon
761
Encore Capital Group
ECPG
$2.15B
$66.7M 0.01%
1,583,201
-365,450
-19% -$16.7M
M icon
762
Macy's
M
$6.27B
$66.4M 0.01%
2,637,523
-167,316
-6% -$3.67M
FIVE icon
763
Five Below
FIVE
$13.4B
$66.3M 0.01%
999,951
-16,380
-2% -$984K
TRV icon
764
Travelers Companies
TRV
$77.2B
$66.3M 0.01%
488,429
-19,361
-4% -$2.56M
KT icon
765
KT
KT
$9.03B
$65.6M 0.01%
4,203,271
+384,800
+10% +$5.67M
ELME
766
Elme Communities
ELME
$144M
$65.6M 0.01%
2,107,818
-72,120
-3% -$2.34M
XEC
767
DELISTED
CIMAREX ENERGY CO
XEC
$64.9M 0.01%
532,280
-4,622
-0.9% -$539K
MMS icon
768
Maximus
MMS
$2.94B
$64.6M 0.01%
902,499
+29,879
+3% +$2.01M
AFL icon
769
Aflac
AFL
$60.7B
$64.6M 0.01%
1,471,856
-52,590
-3% -$2.24M
TBPH icon
770
Theravance Biopharma
TBPH
$878M
$64.6M 0.01%
2,315,540
+15,244
+0.7% +$451K
LDL
771
DELISTED
Lydall, Inc.
LDL
$64.4M 0.01%
1,268,803
+6,014
+0.5% +$329K
ACBI
772
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
$64.3M 0.01%
3,654,376
-19,140
-0.5% -$330K
BZUN
773
Baozun
BZUN
$168M
$64.3M 0.01%
2,036,236
+962,430
+90% +$31.1M
LYB icon
774
LyondellBasell Industries
LYB
$20.2B
$63.6M 0.01%
576,190
-293,456
-34% -$30.4M
TYL icon
775
Tyler Technologies
TYL
$13.5B
$63.5M 0.01%
358,815
-6,812
-2% -$1.21M

Similar funds

T. Rowe Price Associates's Q4 2017 Portfolio in Review

As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.

  • T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
  • T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
  • T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
  • T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
  • T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
  • T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
  • T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.

Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.